David S Liebeskind
Overview
Explore the profile of David S Liebeskind including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
693
Citations
17500
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pariona-Vargas F, Mun K, Lo E, Starkman S, Sanossian N, Hosseini M, et al.
J Stroke Cerebrovasc Dis
. 2025 Mar;
34(5):108278.
PMID: 40054793
Background: Preclinical studies have found marked diurnal/circadian variation in the effect of neuroprotective agents in acute ischemic stroke. However, the presence of diurnal variation in treatment outcomes after neuroprotective therapy...
2.
Salim H, Yedavalli V, Lakhani D, Milhem F, Musmar B, Adeeb N, et al.
J Neurointerv Surg
. 2025 Mar;
PMID: 40044412
Background: Mechanical thrombectomy (MT) is established as an effective treatment for large vessel occlusion strokes, but its efficacy and safety for medium vessel occlusions (MeVOs) remain less clear. This study...
3.
4.
Beyeler M, Rohner R, Ijas P, Eker O, Cognard C, Bourcier R, et al.
Clin Neuroradiol
. 2025 Feb;
PMID: 39976740
Background: The susceptibility vessel sign (SVS) on baseline MRI in acute ischemic stroke patients has been associated with better outcomes post-thrombectomy. This study aimed to investigate whether the presence of...
5.
Leng X, Nie X, Yan H, Pan Y, Zheng L, Liu Y, et al.
Int J Stroke
. 2025 Feb;
:17474930251324463.
PMID: 39956829
Background: Collateral circulation provides compensatory flow to ischemic brain regions in acute large vessel occlusion (LVO), which had been associated with better outcomes after endovascular treatment (EVT). Aims: We aimed...
6.
Salim H, Salim H, Yedavalli V, Milhem F, Musmar B, Adeeb N, et al.
Int J Stroke
. 2025 Jan;
:17474930251317883.
PMID: 39873268
Background: Acute ischemic stroke (AIS) from distal medium vessel occlusion (DMVO) presents unique treatment challenges. Mechanical thrombectomy (MT) is emerging as a viable option for these patients, yet the role...
7.
Faizy T, Yedavalli V, Salim H, Lakhani D, Musmar B, Adeeb N, et al.
J Neurointerv Surg
. 2025 Jan;
PMID: 39855674
Background: Current randomized controlled trials are investigating the efficacy and safety of mechanical thrombectomy (MT) in patients with medium vessel occlusion (MeVO) stroke. Whether best medical management (MM) is more...
8.
Musmar B, Salim H, Adeeb N, Yedavalli V, Lakhani D, El Naamani K, et al.
Neuroradiology
. 2025 Jan;
67(1):201-211.
PMID: 39812774
Introduction: Mechanical thrombectomy (MT) efficacy in medium vessel occlusion (MeVO) stroke, particularly in patients with low Alberta Stroke Program Early Computed Tomography Score (ASPECTS), remains less explored. Methods: This retrospective...
9.
Misra S, Wang S, Quinn T, Dawson J, Zelano J, Tanaka T, et al.
Neurology
. 2025 Jan;
104(3):e210231.
PMID: 39808752
Background And Objectives: The most effective antiseizure medications (ASMs) for poststroke seizures (PSSs) remain unclear. We aimed to determine outcomes associated with ASMs in people with PSS. Methods: We systematically...
10.
Liebeskind D, Tariq M, Kaneko N, Hinman J
Stroke Vasc Interv Neurol
. 2025 Jan;
4(6.
PMID: 39780961
No abstract available.